Saturday 17 October 2026
Export PETS’s income statement to Excel — free account
PetMed Express, Inc.
PETS Healthcare Pharmaceutical Retailers
PetMed Express, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $179.0 million, down 21.1% from fiscal 2025. In the quarter to June 2026, revenue fell 19.9%, EPS grew 83.0% and free cash flow grew 38.6%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
1.20
0.02
−1.64%
Follow PETS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (78.58%) | (100.45%) | (100.63%) | (78.90%) |
+8 more TTM periods Free account |
|
Piotroski F-Score |
3 | 3 | 3 | 2 | |
| (33.73%) | (49.84%) | (55.74%) | (44.67%) | ||
ROIC |
(194.08%) | (487.12%) | (630.14%) | (439.47%) | |
Return on Tangible Assets |
(239.60%) | (320.82%) | (304.68%) | (176.87%) | |
Average Days of Receivables |
3.69 | 3.89 | 3.04 | 3.62 | |
Free Cash Flow per Share |
(1.28) | (1.58) | (1.09) | (0.75) | |
Free Cash Flow |
(27.77) | (33.01) | (22.92) | (15.68) | |
Capital Expenditures |
(3.96) | (4.61) | (6.28) | (7.08) | |
| Other line items | |||||
Cash ROIC |
(77.00%) | (65.56%) | (38.41%) | (19.81%) | |
Accounts Receivable Turnover |
102.00 | 84.74 | 97.94 | 110.61 | |
Accounts Payable Turnover |
7.53 | 5.79 | 8.67 | 7.77 | |
Inventory Turnover |
9.07 | 8.64 | 11.29 | 10.06 | |
Average Days of Payables |
36.88 | 59.24 | 54.69 | 49.80 | |
Days of Inventory on Hand |
25.40 | 38.56 | 32.88 | 38.47 | |
Tax Rate |
0.00 | 0.00 | 0.10 | 0.13 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
40.67% | 40.36% | 39.03% | 35.53% | |
Share Based Compensation of Revenue |
0.58% | 0.76% | 0.90% | 0.95% | |
Operating CF/Net income |
0.81 | 0.50 | 0.26 | 0.16 | |
Depreciation/Fixed assets |
0.37 | 1.39 | 0.37 | 0.33 | |
Capex/Depreciation |
(0.43) | (0.13) | (0.61) | (0.75) | |
Revenue per Share |
7.79 | 8.56 | 8.90 | 9.49 | |
Operating CF per Share |
(1.10) | (1.36) | (0.79) | (0.41) | |
Capex per Share |
(0.18) | (0.22) | (0.30) | (0.34) | |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.04 |
Columns are period end dates